Holds 2 active US DMFs for famciclovir, filing since 2010. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds 2 active US DMFs for famciclovir, filing since 2010. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds one active US DMF for famciclovir, filing since 2009. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 29 markets.
Holds one active US DMF for famciclovir, filing since 2006. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
Holds one active US DMF for famciclovir, filing since 2008. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for famciclovir, filing since 2020. Its 2023 FDA inspection closed as NAI.
Holds one active US DMF for famciclovir, filing since 2019. Its 2024 FDA inspection closed as NAI.
Holds one active US DMF for famciclovir, filing since 2006. Its GMP is recognised in 1 market.
Holds one active US DMF for famciclovir, filing since 2009.
Registered with PMDA (Japan) for famciclovir.
The names are listed below. Ask Fred about the filings, inspection history and GMP certificates on record for each manufacturer.
Contract manufacturers make to order rather than holding their own filing for this molecule.
The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Every factor appears on the card it produced. Read the full method.
Ask Fred which manufacturers are on record for famciclovir and what filings they hold.
Chat with Fred, your AI analyst